Sign In
Buy JNJ
$231.29
+2.90 (+1.27%)
At Close: Jun 22, 2026
Big Tech Is Spending $700 Billion. These Companies Get Paid.
12:00am, Monday, 04'th May 2026
Big Tech earnings reveal where $700 billion in AI spending is flowing - and why the biggest winners aren't the obvious stocks.
J&J's $1.7 Billion Drug Ushers in Age of Psychedelic Medicine
04:00am, Saturday, 02'nd May 2026
Spravato, the ketamine-derived nasal spray from Johnson & Johnson, was once seen as a long shot. It was difficult to deliver, heavily regulated and slow to catch on.
Why Johnson & Johnson (JNJ) is a Top Dividend Stock for Your Portfolio
12:45pm, Friday, 01'st May 2026
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes?
Half of Americans Think $1,000 Is Needed to Start Investing, They’re Wrong
08:29am, Thursday, 30'th Apr 2026
A perception gap is keeping millions of Americans on the sidelines of the stock market. This is especially true if you look at Charles Schwab's 2025 Modern Wealth Survey, which found that roughly half
Johnson & Johnson Appoints Ryan Koors as Vice President, Investor Relations
08:02am, Thursday, 30'th Apr 2026
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) (the “Company”) today announced the appointment of Ryan Koors to Vice President, Investor Relations, effective May 7, 2026. Mr.
3 Unstoppable Growth Stocks For Years Of Passive Income
07:42am, Thursday, 30'th Apr 2026
Passive income separates a paycheck from a portfolio. Earned income stops when you stop working, but dividends landing quarterly do not.
Want to Build Real Wealth in Healthcare? These Stocks Are Worth Considering
06:10am, Thursday, 30'th Apr 2026
These companies are leaders in their fields.
46% of Americans Split Their Investments Into Separate Buckets. Should Your Retirement Strategy Too?
02:12pm, Wednesday, 29'th Apr 2026
The Charles Schwab Modern Wealth Survey 2025 found that 46% of American investors maintain a main investment portfolio alongside one or more smaller, separate portfolios designated for different finan
3 Dividend Kings That Have Outrun the Nasdaq Over 12 Months
11:37am, Wednesday, 29'th Apr 2026
The Nasdaq Index carries companies that are known for moving fast and breaking things.
Jim Cramer: This Tech Stock Is A 'Winner', Snap Does Not Have Growth
08:27am, Wednesday, 29'th Apr 2026
On CNBC's “Mad Money Lightning Round,” Jim Cramer said Ondas Inc (NASDAQ:ONDS) is losing a lot of money and added that he would rather have to find something new and different that is distinct, wh
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)?
07:21am, Wednesday, 29'th Apr 2026
Designed to provide broad exposure to the Healthcare - Pharma segment of the equity market, the Invesco Pharmaceuticals ETF (PJP) is a passively managed exchange traded fund launched on June 23, 2005.
J&J Sees Continued MedTech Improvement in Q1, Eyes Better 2026
01:15pm, Tuesday, 28'th Apr 2026
Johnson & Johnson's JNJ medical devices segment, known as MedTech, offers products in the orthopedics, surgery, cardiovascular and vision markets. The MedTech segment accounts for around 36% of J&J's
Why These 3 Forever Stocks Belong on Your Watchlist
11:10am, Tuesday, 28'th Apr 2026
These companies have proved to be good stocks to buy and hold for the long term.
Warren Buffett Owns 3 Strong Buy Dividend Aristocrat Giants—1 for Almost 40 Years
08:13am, Tuesday, 28'th Apr 2026
Warren Buffett stepped down as chief executive of Berkshire Hathaway (NYSE: BRK-B | BRK-B Price Prediction) on December 31, 2025, after six decades leading the conglomerate he transformed from a stru
Johnson & Johnson to Participate in the Bernstein's 42nd Annual Strategic Decisions Conference
04:33pm, Monday, 27'th Apr 2026
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) will present at the Bernstein's 42nd Annual Strategic Decisions Conference on Wednesday, May 27th, 2026. Management will participate
